LncRNA H19通过失调选择性剪接和甲硫氨酸代谢促进酒精相关性肝病
研究检测到酒精性肝硬化和肝炎患者外周血与肝脏及乙醇喂养小鼠肝脏中H19水平升高,肝内过表达H19加重乙醇诱导的肝脂肪变性和损伤;机制上H19通过PTBP1调控BHMT选择性剪接减少甲硫氨酸合成,敲除H19或恢复BHMT可改善脂肪变性。
要点
- 酒精性肝硬化、肝炎患者外周血和肝脏及乙醇喂养小鼠肝脏中H19水平升高。
- 肝内过表达H19加重乙醇诱导的肝脂肪变性和损伤。
- H19通过PTBP1调控BHMT选择性剪接,减少甲硫氨酸合成。
核心结论
- 本研究揭示H19通过PTBP1介导的BHMT调控影响酒精相关性肝病中甲硫氨酸代谢的新机制。
- 靶向H19-PTBP1-BHMT通路可能为酒精相关性肝病提供新的治疗途径。
研究设计与样本
- 研究检测酒精性肝硬化、酒精性肝炎患者外周血和肝脏及乙醇喂养小鼠肝脏中H19水平。
- 采用肝内过表达H19小鼠、H19母源特异性敲除(H19Mat+/-)小鼠和肝特异性敲除H19差异甲基化域(H19DMDHep-/-)小鼠进行实验。
主要发现
- 酒精性肝硬化和肝炎患者外周血和肝脏及乙醇喂养小鼠肝脏中H19水平升高。
- 肝内过表达H19加重乙醇诱导的肝脂肪变性和损伤。
- 代谢组学分析显示H19过表达小鼠肝脏中甲硫氨酸水平降低,归因于H19介导的BHMT抑制。
- H19通过PTBP1调控BHMT选择性剪接,导致Bhmt蛋白编码变体减少。
- 乙醇喂养小鼠中H19Mat+/-或H19DMDHep-/-上调BHMT表达并改善肝脂肪变性,恢复BHMT可抵消H19诱导的乙醇介导肝脂肪变性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Long noncoding RNAs constitute a significant portion of the human genome. Among these, lncRNA H19, initially identified for its high expression during fetal development followed by a decline in the liver postnatally, re-emerges in various liver diseases. However, its specific role in alcohol-associated liver disease (ALD) remains unclear. APPROACH AND RESULTS: Elevated H19 levels were detected in peripheral blood and livers of patients with alcohol-associated cirrhosis and hepatitis, as well as in livers of ethanol-fed mice. Hepatic overexpression of H19 exacerbated ethanol-induced liver steatosis and injury. Metabolomics analysis revealed decreased methionine levels in H19-overexpressed mouse livers, attributable to H19-mediated inhibition of betaine homocysteine methyltransferase (BHMT), a crucial enzyme in methionine synthesis. H19 regulated BHMT alternative splicing through polypyrimidine tract-binding protein 1 (PTBP1), resulting in a reduced Bhmt protein-coding variant. The maternally specific knockout of H19 ( H19Mat+/- ) or liver-specific knockout of the H19 differentially methylated domain ( H19DMDHep-/- ) in ethanol-fed mice upregulated BHMT expression and ameliorated hepatic steatosis. Furthermore, BHMT restoration counteracted H19-induced ethanol-mediated hepatic steatosis. CONCLUSIONS: This study identifies a novel mechanism whereby H19, via PTBP1-mediated BHMT regulation, influences methionine metabolism in ALD. Targeting the H19-PTBP1-BHMT pathway may offer new therapeutic avenues for ALD.
引用
- Yang Z, Jiang Y, Ma J, et al. LncRNA H19 promoted alcohol-associated liver disease through dysregulation of alternative splicing and methionine metabolism. Hepatology. 2024. PMID: 39364651. doi:10.1097/HEP.0000000000001078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。